Study of BD200 for advanced or metastatic solid tumors
Part of Cancer clinical trials.
This early-stage trial tests a new drug called BD200 for people with advanced or metastatic solid tumors. The goal is to check the safety, how the body handles the drug, and whether it can shrink tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a solid tumor cancer that has spread, come back, or cannot be removed by surgery
- You must have already tried other available treatments that did not work or are not suitable
- You must be willing to provide tumor biopsy samples (small pieces of tissue)
- You must be generally in good health and able to handle daily activities (ECOG 0 or 1)
- You must not have serious heart, lung, liver, stomach, skin, or eye problems, active infections, or autoimmune diseases
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called MDX2004 for people with advanced solid tumors (cancer that has spread or can't be removed). The goal is to see if the drug is safe and if it helps shrink tumors.
This trial tests a new drug, MDX2001, for people with advanced solid tumors that have spread. The study aims to find the best dose and see how well it works.
This trial tests a new drug, BG-75098, alone or with other treatments, for adults with advanced solid tumors that have spread or cannot be removed. It may be an option if you have already tried standard treatments or if they are not suitable for you.
This trial tests a new drug called HDM2006 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective.
This trial tests a new drug called BG-C137 for people with advanced solid tumors that have stopped responding to other treatments. The drug targets a protein called FGFR2b found on some cancer cells, aiming to deliver a therapy directly to the tumor.
This trial tests an experimental drug, BA1203, for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and whether it can help shrink tumors.
Hear when a new Solid Tumor (Phase I) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.